MedTrace Logo

Efficacy of a Web-based Sexual Violence Risk Reduction Program for Female College Students

NCT03726437 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 881

Last updated 2023-02-13

Study results available
· View outcomes & findings →

Summary

This study evaluates the efficacy of a web-based program for female college freshmen ("RealConsent") in reducing their risk of sexual violence victimization. Half the participants will receive RealConsent-F and half will receive an attention-placebo control ("Stress and Mood Management").

Conditions

  • Sexual Violence

Interventions

BEHAVIORAL

RealConsent

This 3-hour web-based program consists of four 45-minute modules that are interactive and range in number of segments (1-14) and types of activities. Each of the modules involves interactivity, didactic activities and two episodes of a serial drama ("Squad"), which allow for the modeling of positive behaviors and illustrate both positive and negative outcome expectations. Behaviors modeled include drinking safely (e.g., eating before drinking, pacing, and drinking water), having a game plan before going out, communicating with male sex partners, engaging in protective dating behaviors, use of resistance strategies, self-defense strategies and bystander intervention with the goal of reducing risk of being sexually assaulted.

BEHAVIORAL

Stress and Mood Management

This 3-hour general health promotion web-based program consists of four 45-minute modules ("Stress Management", "Managing Depression", "Managing Anxiety", and "Treatments that work") that provide a range of activities related to reducing day-to day stress and alleviating anxiety through meditation and exercise.

Sponsors & Collaborators

  • Behavioral Science Technologies, LLC

    collaborator INDUSTRY

  • Georgia State University

    lead OTHER

Principal Investigators

  • Laura F. Salazar, PhD · Georgia State University

  • Anne Marie Schipani-McLaughlin, PhD · Georgia State University

  • George Cavagnaro, MBA · Behavioral Science Technologies, LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
20 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-17
Primary Completion
2019-11-01
Completion
2019-11-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03726437 on ClinicalTrials.gov